Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04038255 · ClinicalTrials.gov registry record · Phase 4
Mindfulness Based Smoking Cessation Among Cancer Survivors
A Phase 4 study, sponsored by University of Miami.
- Terminated
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT04038255: Clinical Trial Phase 4 study, sponsored by University of Miami.
NCT04038255 is a Phase 4 study that was terminated before completion, run by University of Miami. The registered enrollment target is 20 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04038255, a Phase 4 study, was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study will examine the effect of a mindfulness-based smoking cessation program among cancer survivors.
Primary Outcome
Number of participants who self-report of not smoking in the past 7-days, not even a puff, confirmed by expired carbon monoxide (CO) level of \< 10 ng/ml.
Interventions
- DRUG Nicoderm C-Q Transdermal Product
- BEHAVIORAL Orientation session
- BEHAVIORAL Craving-to-Quit app
- BEHAVIORAL Two brief follow-up phone calls
- BEHAVIORAL Group MT sessions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-09-28 |
| Est. Completion | 2024-05-19 |
| Phase | Phase 4 |
Why NCT04038255 stopped before completion
NCT04038255 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 5 interventions - of which Nicoderm C-Q Transdermal Product is the first listed.
NCT04038255 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04038255 about?
NCT04038255 is a clinical study titled "Mindfulness Based Smoking Cessation Among Cancer Survivors". This study will examine the effect of a mindfulness-based smoking cessation program among cancer survivors.
What is the current status of trial NCT04038255?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2019-09-28. Estimated completion is 2024-05-19.
What interventions are being tested in trial NCT04038255?
The interventions under investigation include: Nicoderm C-Q Transdermal Product (DRUG), Orientation session (BEHAVIORAL), Craving-to-Quit app (BEHAVIORAL), Two brief follow-up phone calls (BEHAVIORAL), Group MT sessions (BEHAVIORAL).
Who is sponsoring clinical trial NCT04038255?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04038255's enrollment target sits among peer trials
20 1753rd of 2000 higher than 167 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI